Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2010 | 12-2009 | 09-2009 | 06-2009 | 03-2009 | |
| Sales | 856,500 | 785,700 | 662,100 | 677,800 | 667,400 |
| Cost of Goods | 504,700 | 461,300 | 353,700 | 393,100 | 388,700 |
| Gross Profit | 351,800 | 324,400 | 308,400 | 284,700 | 278,700 |
| Operating Expenses | 252,200 | 224,500 | 198,400 | 193,300 | 197,900 |
| Operating Income | 100,300 | 100,200 | 110,700 | 91,500 | 81,500 |
| Interest Expense | 20,300 | 15,900 | 9,000 | 4,600 | 4,700 |
| Other Income | 26,500 | 5,400 | 600 | 3,700 | 3,200 |
| Pre-tax Income | 106,500 | 89,700 | 102,300 | 90,600 | 80,000 |
| Income Tax | 36,700 | 32,800 | 39,300 | 37,600 | 30,900 |
| Net Income Continuous | 69,800 | 56,900 | 63,000 | 53,000 | 49,100 |
| Net Income | $69,800 | $56,900 | $63,000 | $53,000 | $49,100 |
| EPS Basic Total Ops | 0.57 | 0.51 | 0.61 | 0.51 | 0.48 |
| EPS Basic Continuous Ops | 0.57 | 0.52 | 0.61 | 0.51 | 0.48 |
| EPS Diluted Total Ops | 0.57 | 0.52 | 0.55 | 0.46 | 0.43 |
| EPS Diluted Continuous Ops | 0.57 | 0.51 | 0.54 | 0.45 | 0.42 |
| EBITDA(a) | $164,000 | $151,600 | $157,100 | $137,700 | $126,500 |